China Next-Generation Sequencing Market Report & Forecast 2021-2027

This report contains market size and forecasts of Next-Generation Sequencing in China, including the following market information:
China Next-Generation Sequencing Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Next-Generation Sequencing companies in 2020 (%)
The global Next-Generation Sequencing market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Next-Generation Sequencing market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Next-Generation Sequencing Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Next-Generation Sequencing Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Next-Generation Sequencing Market Segment Percentages,

By Type

, 2020 (%)
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing

China Next-Generation Sequencing Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Next-Generation Sequencing Market Segment Percentages,

By Application

, 2020 (%)
Oncology
Hereditary Disease Detection
Life Science

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next-Generation Sequencing revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Next-Generation Sequencing revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
BGI
Illumina
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Qiagen
Genotypic Technology
Genewiz
Dna Link
Takara
Scigenom Labs
Novogene
Personalis

Frequently Asked Questions